US Stocks
/
Sarepta Therapeutics, Inc.  (DE) Share Price

Sarepta Therapeutics, Inc. (DE) Share Price

NASDAQ: SRPT | Small Cap
$17.89
+$0.41 (2.32%) Last updated on 09 Oct, 2026 | 00:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sarepta Therapeutics, Inc. (DE) Stock Performance

Open
$17.36
Prev. Close
$17.49
Circuit Range
N/A
Day Range
$17.27 - $18.13
Year Range
$14.70 - $25.30
Volume
72,129
Average Traded
$17.66

Sarepta Therapeutics, Inc. (DE) Share Price Today

As of 9 October 2026, Sarepta Therapeutics, Inc. (DE)'s share price is $17.89. The stock opened at $17.36, compared to its previous close of $17.49. During today's trading session, Sarepta Therapeutics, Inc. (DE)'s share price traded between $17.27 and $18.13, with an average price of $17.70. Over the past 52 weeks, the stock has recorded a high of $25.30 and a low of $14.70. In terms of performance, Sarepta Therapeutics, Inc. (DE)'s share price has declined by 14.25% over the last six months and is down 25.44% on a year-on-year basis.

Sarepta Therapeutics, Inc. (DE) Share Price Chart

$17.27$18.13
L
Show Current Price
H

Sarepta Therapeutics, Inc. (DE) Stock Fundamentals & Key Indicators

Market Cap
$1.79B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.29
Revenue (TTM)
$2.20T
Return On Equity (TTM)
-8.95%
Profit Margin
-32.45%
Debt to Equity
0.55
Quarterly Earnings Growth YoY
97.28%

Sarepta Therapeutics, Inc. (DE) Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$399.36$442.93$730.80$401.25
Net Profit-$179.95-$282.85$330.96-$4.89
Net Profit Margin-45.06%-63.86%45.29%-1.22%
Income ChangeN/A-57.18%217.01%-101.48%

Sarepta Therapeutics, Inc. (DE) Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$933.01$1243.34$1901.98$2198.24
Net Profit-$703.49-$535.98$235.24-$713.41
Net Profit Margin-75.40%-43.11%12.37%-32.45%
Income ChangeN/A23.81%143.89%-403.27%

About Sarepta Therapeutics, Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Sarepta Therapeutics, Inc. (DE) Historical Returns

MonthOpenCloseChange %
Oct 2026
$17.98
$17.94
-1.64%
Sep 2026
$21.07
$18.24
-15.48%
Aug 2026
$14.99
$21.58
+45.37%
Jul 2026
$18.30
$14.85
-17.48%
Jun 2026
$17.61
$17.99
+0.56%
May 2026
$20.97
$17.89
-14.28%
Apr 2026
$21.85
$20.87
-4.00%
Mar 2026
$16.12
$21.74
+29.71%
Feb 2026
$19.91
$16.76
-17.54%
Jan 2026
$21.85
$20.32
-5.53%
Dec 2025
$20.91
$21.52
+0.87%
Nov 2025
$24.17
$21.33
-11.13%

SRPT Share Price FAQs

What is Sarepta Therapeutics, Inc. (DE) share price today?

chevron-up
Sarepta Therapeutics, Inc. (DE) share price today is $17.89 as on October 9, 2026 at 12:27 am IST.

What is the 52 week high and 52 week low of Sarepta Therapeutics, Inc. (DE) stock?

chevron-up
The 52 week high of Sarepta Therapeutics, Inc. (DE) stock is $25.30, while the 52 week low is $14.70 as of 9 Oct '26.

What is SRPT's market capitalisation today?

chevron-up
SRPT market capitalisation is $1.79B as of October 9, 2026, at 12:27 am IST.

What is SRPT's net income for the last quarter?

chevron-up
SRPT's net income for the last quarter is -4.89B USD.

What is the 5 year returns of SRPT?

chevron-up
The 5 year returns of SRPT is -77.39% as on 9 Oct '26.

What is the high & low stock price of SRPT today?

chevron-up
SRPT stock price hit a high of $18.13 and low of $17.27 as of 9 Oct '26.

Can I buy SRPT shares in India?

chevron-up
Yes. You can buy SRPT in India by opening an international trading account.